Prelude Therapeutics Announces First Quarter 2023 Financial Results, Operations Update - MyChesCo
WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD) reported financial results for the first quarter ended March 31, 2023, and provided an update on recent clinical and development pipeline progress. …
MyChesCo
